Zhang Zhen, Jiang Maoyuan, Wei Xinyi, Shi Jinfeng, Geng Zhao, Yang Shasha, Fu Chaomei, Guo Li
1The Ministry of Education Key Laboratory of Standardization of Chinese Herbal Medicine, State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137 China.
Sichuan Institute for Food and Drug Control, Chengdu, 611137 China.
Chin Med. 2019 Mar 1;14:6. doi: 10.1186/s13020-019-0227-z. eCollection 2019.
Fuzi-Lizhong pill (FZLZP), which was first recorded in the Classic-"Taiping Huimin Heji Ju Fang" of the Song Dynasty, has been widely used to treat gastrointestinal disease in clinic for thousands of years in China. However, an in-depth understanding of the chemical constituents of FZLZP and its potential bioactive constituents is lacking.
A simple, sensitive and selective method of high-performance liquid chromatography coupled with quadrupole-time-of-flight high-definition mass spectrometry (HPLC-Q-TOF/MS) and automated data analysis (Agilent MassHunter Qualitative Analysis B.06.00 Workstation Software) was developed to simultaneously identify the chemical constituents of FZLZP and the absorbed prototypes as well as the metabolites in rat serum after the oral administration of FZLZP.
Sixty-seven compounds, including alkaloids, flavonoids, triterpenes, gingerols, phenylpropanoids and volatile oil, in the FZLZP extract were tentatively characterized by comparing the retention time and mass spectrometry data and retrieving the reference literatures. Additionally, 23 prototype compounds and 3 metabolites in the rat serum samples were identified after oral administration of FZLZP, which might be the potential active components in vivo. In addition, the absorption of alkaloids decreased when Debx. was in the form of combined application as a prescription compared to when it was in the form of herb powder.
Herein, the chemical constituent in vitro and the absorbed compounds in the serum of a traditional Chinese formula, Fuzi-Lizhong pill, were fully characterized using a rapid and comprehensive analysis approach based on high-performance liquid chromatography combined with quadrupole time-of-flight mass spectrometry coupled to MassHunter Qualitative Analysis software data processing approach. The results provide helpful chemical information on FZLZP for further pharmacology and active mechanism research. In view of the bioactive constitutes that basically were derived from these absorbed compounds in vivo, this work could provide a useful strategy to explore the bioactive substances of traditional Chinese medicine.
附子理中丸最早记载于宋代的《太平惠民和剂局方》,在中国临床上已被广泛用于治疗胃肠道疾病达数千年之久。然而,目前对附子理中丸的化学成分及其潜在生物活性成分缺乏深入了解。
建立了一种简单、灵敏且具有选择性的高效液相色谱-四极杆-飞行时间高清质谱联用(HPLC-Q-TOF/MS)及自动数据分析方法(安捷伦MassHunter定性分析B.06.00工作站软件),用于同时鉴定附子理中丸的化学成分、口服给药后大鼠血清中的吸收原型及代谢产物。
通过比较保留时间和质谱数据并检索参考文献,初步鉴定了附子理中丸提取物中的67种化合物,包括生物碱、黄酮类、三萜类、姜辣素、苯丙素类和挥发油。此外,口服附子理中丸后,在大鼠血清样本中鉴定出23种原型化合物和3种代谢产物,这些可能是体内潜在的活性成分。此外,与以药粉形式存在时相比,当附子理中丸以方剂形式联合应用时,生物碱的吸收减少。
本文采用基于高效液相色谱结合四极杆飞行时间质谱联用MassHunter定性分析软件数据处理方法的快速综合分析方法,对中药复方附子理中丸的体外化学成分和血清中的吸收化合物进行了全面表征。研究结果为进一步开展附子理中丸的药理及作用机制研究提供了有用的化学信息。鉴于生物活性成分基本来源于体内这些吸收的化合物,本研究可为探索中药生物活性物质提供一种有用的策略。